Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

被引:28
|
作者
Alaaeldin, Rania [1 ]
Ali, Fares E. M. [2 ]
Bekhit, Amany Abdlrehim [3 ]
Zhao, Qing-Li [4 ]
Fathy, Moustafa [3 ,5 ]
机构
[1] Deraya Univ, Fac Pharm, Dept Biochem, Al Minya 61111, Egypt
[2] Al Azhar Univ, Fac Pharm, Dept Pharmacol & Toxicol, Assiut Branch, Assiut 71524, Egypt
[3] Minia Univ, Fac Pharm, Dept Biochem, Al Minya 61519, Egypt
[4] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol, Toyama 9300194, Japan
[5] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 9300194, Japan
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
azilsartan; breast cancer; NF-kB; EMT; IL-6; JAK2; STAT3; SLUG; TWIST; SNAIL; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; APOPTOSIS; RECEPTOR; EMT; COMBINATIONS; INFLAMMATION; MODULATION; MIGRATION; SLUG;
D O I
10.3390/molecules27227825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastatic breast cancer is an incurable form of breast cancer that exhibits high levels of epithelial-mesenchymal transition (EMT) markers. Angiotensin II has been linked to various signaling pathways involved in tumor cell growth and metastasis. The aim of this study is to investigate, for the first time, the anti-proliferative activity of azilsartan, an angiotensin II receptor blocker, against breast cancer cell lines MCF-7 and MDA-MB-231 at the molecular level. Cell viability, cell cycle, apoptosis, colony formation, and cell migration assays were performed. RT-PCR and western blotting analysis were used to explain the molecular mechanism. Azilsartan significantly decreased the cancer cells survival, induced apoptosis and cell cycle arrest, and inhibited colony formation and cell migration abilities. Furthermore, azilsartan reduced the mRNA levels of NF-kB, TWIST, SNAIL, SLUG and bcl2, and increased the mRNA level of bax. Additionally, azilsartan inhibited the expression of IL-6, JAK2, STAT3, MMP9 and bcl2 proteins, and increased the expression of bax, c-PARP and cleaved caspase 3 protein. Interestingly, it reduced the in vivo metastatic capacity of MDA-MBA-231 breast cancer cells. In conclusion, the present study revealed, for the first time, the anti-proliferative, apoptotic, anti-migration and EMT inhibition activities of azilsartan against breast cancer cells through modulating NF-kB/IL-6/JAK2/STAT3/MMP9, TWIST/SNAIL/SLUG and apoptosis signaling pathways.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells
    Gao, Yebo
    Li, Weidong
    Liu, Rui
    Guo, Qiujun
    Li, Jie
    Bao, Yanju
    Zheng, Honggang
    Jiang, Shulong
    Hua, Baojin
    ONCOLOGY REPORTS, 2017, 38 (02) : 1224 - 1232
  • [2] IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
    Wu, Xiongyan
    Tao, Pan
    Zhou, Quan
    Li, Jie
    Yu, Zhenjia
    Wang, Xiaofeng
    Li, Jiaanfang
    Li, Chen
    Yan, Min
    Zhu, Zhenggang
    Liu, Bingya
    Su, Liping
    ONCOTARGET, 2017, 8 (13) : 20741 - 20750
  • [3] PDSS2 Promotes Epithelial-Mesenchymal Transition and Angiogenesis in Breast Cancer Cells by Activating the NF-KB Pathway
    Shi, Zhijie
    Wu, Deqi
    Hu, Yangying
    Zheng, Shusen
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05) : 2551 - 2560
  • [4] ANXA1 enhances tumor proliferation and migration by regulating epithelial-mesenchymal transition and IL-6/JAK2/STAT3 pathway in papillary thyroid carcinoma
    Zhao, Xin
    Ma, Weiguo
    Li, Xinyu
    Li, Haijun
    Li, Jin
    Li, Hongle
    He, Fucheng
    JOURNAL OF CANCER, 2021, 12 (05): : 1295 - 1306
  • [5] The role of IL-6/JAK2/STAT3 signaling pathway in cancers
    Huang, Bei
    Lang, Xiaoling
    Li, Xihong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6
    Xu, Minmin
    Ren, Li
    Fan, Jinhua
    Huang, Lu
    Zhou, Liming
    Li, Xuegang
    Ye, Xiaoli
    LIFE SCIENCES, 2022, 290
  • [7] Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
    Yu, Dinglai
    Ye, Tingting
    Xiang, Yukai
    Shi, Zhehao
    Zhang, Jie
    Lou, Bin
    Zhang, Fan
    Chen, Bicheng
    Zhou, Mengtao
    ONCOTARGETS AND THERAPY, 2017, 10 : 4719 - 4729
  • [8] Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling
    Liu, Wei
    Wang, Xindi
    Wang, Le
    Mei, Yu
    Yun, Yanning
    Yao, Xiaobao
    Chen, Qian
    Zhou, Jinsong
    Kou, Bo
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (06): : 965 - 974
  • [9] Tanshinone IIA Inhibits Breast Cancer Stem Cells Growth In Vitro and In Vivo Through Attenuation of IL-6/STAT3/NF-kB Signaling Pathways
    Lin, Caiyu
    Wang, Li
    Wang, Hong
    Yang, Liuqi
    Guo, Huijie
    Wang, Xiujie
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (09) : 2061 - 2070
  • [10] Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells
    Chen, Jingfeng
    Wang, Silu
    Su, Jiadong
    Chu, Guanyu
    You, Heyi
    Chen, Zongjing
    Sun, Hongwei
    Chen, Bicheng
    Zhou, Mengtao
    ONCOTARGETS AND THERAPY, 2016, 9 : 4225 - 4237